Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Passive antibody to enterotoxigenic E: Will start Phase I/II testing in the second quarter

ImmuCell Corp. (ICCC),

Read the full 31 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE